This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Lts Lohmann Therapie-Systeme Ag. Active years: 2003-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2023
Title: Elvira Kirstgen: Innovator in Active Substance Laminate Technology
Introduction
Elvira Kirstgen is a notable inventor based in Neuwied, Germany. She has made significant contributions to the field of pharmaceutical technology, particularly in the development of active substance laminates. With a total of two patents to her name, her work focuses on innovative methods for producing effective drug delivery systems.
Latest Patents
Kirstgen's latest patents include a method for producing an oral active substance laminate. This invention relates to a process that involves creating a laminate with at least one active-substance-containing layer arranged on a substrate. The method aims to enhance the efficiency of drug delivery, particularly for oral applications. Another significant patent is for an estradiol-containing patch designed for transdermal application of hormones. This active substance-containing patch allows for the controlled release of estradiol or its pharmaceutically acceptable derivatives. It features a backing layer, an active substance-containing reservoir, and a detachable protective layer, with the innovative use of pressure-sensitive adhesives that include wool wax or components thereof and zinc oxide.
Career Highlights
Elvira Kirstgen has established herself as a key figure in her field through her innovative work at LTS Lohmann Therapie-Systeme AG. Her expertise in developing advanced drug delivery systems has positioned her as a leader in pharmaceutical technology.
Collaborations
Kirstgen has collaborated with notable colleagues, including Reinhold Meconi and Michael Hoffmann. These partnerships have contributed to her success and the advancement of her inventions.
Conclusion
Elvira Kirstgen's contributions to active substance laminate technology demonstrate her commitment to innovation in the pharmaceutical industry. Her patents reflect her expertise and dedication to improving drug delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
